PI3Kα inhibitors that Inhibit Metastasis
2010
PI3Kα Inhibitors and Tumor Metastasis
publication
Evidence: moderate
Author Information
Author(s): Schmidt-Kittler O, Zhu J, Yang J, Guosheng L, Hendricks W, Lengauer C, Gabelli SB, Kinzler KW, Vogelstein B, Huso DL, Zhou S
Hypothesis
How does PI3Kα regulate metastasis in cancer?
Conclusion
PI3Kα inhibitors may be more effective in preventing the spread of tumors rather than treating established ones.
Supporting Evidence
- PI3Kα is frequently mutated in various cancers, affecting tumor behavior.
- J-series compounds showed selectivity for the p110α isoform in vitro.
- Phospho-AKT levels were inhibited in tumor tissue but did not correlate with tumor growth inhibition.
- PI3Kα inhibitors may be more useful in preventing metastasis rather than treating existing tumors.
Takeaway
This study found that drugs targeting a specific protein in cancer might help stop tumors from spreading to other parts of the body.
Methodology
The study evaluated the effects of PI3Kα-selective inhibitors in vitro and in vivo using HCT116 cancer models.
Limitations
The study's findings need further validation with additional research and specific experimental models.
Want to read the original?
Access the complete publication on the publisher's website